Silo Pharma
SILO
13 hedge funds and large institutions have $285K invested in Silo Pharma in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
76% more capital invested
Capital invested by funds: $162K → $285K (+$123K)
0.1% more ownership
Funds ownership: 0.27% → 0.37% (+0.1%)
13% less funds holding
Funds holding: 15 → 13 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$185K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$30.9K |
| 3 |
CI
Conning Inc
Hartford,
Connecticut
|
+$29.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.2K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$739 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$33.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$17.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$13K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10.1K |
| 5 |
HF
HRT Financial
New York
|
-$10K |
SILO Hedge Fund Activity: Q1 2025 in Review
13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q1 2025, worth a combined $285K — up 76% from $162K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SILO and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $185K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $33.4K sold.
- 13 institutional investors held Silo Pharma (SILO) as of Q1 2025, down from 15 in Q4 2024.
- Funds reported $285K of Silo Pharma stock for Q1 2025, up 76% quarter-over-quarter.
- 4 funds opened new Silo Pharma positions in Q1 2025 and 6 closed out, a net change of -2 holders.
- The largest Silo Pharma buyer in Q1 2025 was AdvisorShares Investments, an estimated $185K added.
- The largest Silo Pharma seller in Q1 2025 was Renaissance Technologies, an estimated $33.4K sold.
Based on aggregated 13F filings for Q1 2025.